Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00902733 · ClinicalTrials.gov registry record · NA

Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer

A NA study of Pain and Pancreatic Cancer, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT00902733: Completed NA study of Pain and Pancreatic Cancer, sponsored by City of Hope Medical Center.

NCT00902733 is a NA study of Pain and Pancreatic Cancer that has completed, run by City of Hope Medical Center. The registered enrollment target is 125 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00902733, a NA study of Pain and Pancreatic Cancer, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Meeting with a nurse to assess symptoms and quality of life may be more effective than standard care in treating patients with pancreatic cancer. PURPOSE: This clinical trial is studying nurse-provided care to see how well it works compared with standard care in treating patients with pancreatic cancer.

Interventions

  • OTHER medical chart review
  • OTHER questionnaire administration
  • PROCEDURE quality-of-life assessment
  • PROCEDURE psychosocial assessment and care
  • PROCEDURE fatigue assessment and management

Study Locations (1)

California

  • City of Hope Comprehensive Cancer Center - Duarte

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2008-07
Est. Completion 2010-02
Phase NA
City of Hope Medical Center

582 total trials

What the finished NCT00902733 record still lists

NCT00902733 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (59% lower).

The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 5 interventions - of which medical chart review is the first listed.

NCT00902733 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00902733 about?

NCT00902733 is a clinical study titled "Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer". RATIONALE: Meeting with a nurse to assess symptoms and quality of life may be more effective than standard care in treating patients with pancreatic cancer. PURPOSE: This clinical trial is studying nurse-provided care to see how well it works compared with standard care in treating patients with pa...

What is the current status of trial NCT00902733?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2008-07. Estimated completion is 2010-02.

What conditions does trial NCT00902733 study?

This clinical trial studies the following conditions: Pain, Pancreatic Cancer, Fatigue, Nausea and Vomiting.

What interventions are being tested in trial NCT00902733?

The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE), fatigue assessment and management (PROCEDURE).

Who is sponsoring clinical trial NCT00902733?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00902733 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00902733's enrollment target sits among peer trials

125 130th of 374 higher than 243 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00902733, the US trial registry maintained by the National Library of Medicine. NCT00902733 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.